Moderators:
Search This Board: 
Created: 03/10/2008 06:08:23 PM - Followers: 3 - Board type: Free - Posts Today: 0
1000 Alfred Nobel Drive Hercules, CA 94547 Phone: 510-724-7000 Fax: 510-724-3167 Web Site: http://www.bio-rad.com Sector: Technology Industry: Scientific & Technical Instruments Full Time Employees: 6,300 Bio-Rad Laboratories, Inc. and its subsidiaries engage in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications in the United States. Its products are also used to identify, analyze, and purify chemical and biological material components. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment supplies technological applications, such as electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification to universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, and food testing laboratories. The Clinical Diagnostics segment offers technologies used in various tests to detect, identify, and quantify substances in blood or other bodily fluids and tissues to hospital laboratories, reference laboratories, physician office laboratories, government agencies, and other diagnostics manufacturers. The company serves customers through direct mail advertising, exhibits at trade shows and technical meetings, telemarketing, e-commerce, advertising in technical and trade publications, as well as through sales force. Bio-Rad Laboratories was founded in 1952 and is headquartered in Hercules, California. Mr. Norman Schwartz, 58 Chief Exec. Officer, Pres Ms. Christine A. Tsingos, 49 Chief Financial Officer and VP Mr. Sanford S. Wadler, 61 VP, Sec. and Gen. Counsel Mr. John Goetz, 58 VP and Group Mang. Mr. James R. Stark, Principal Accounting Officer and Corp. Controller Bio-Rad Laboratories Inc.'s Corporate Governance Quotient (CGQ®) as of 6-Mar-08 is better than 1.4% of Russell 3000 companies and 5.7% of Health Care Equipment & Services companies. Insider transactions: http://finance.yahoo.com/q/it?s=BIO Outstanding Shares 21,889,861 as of Feb 22, 2008 Number of Share Holders of Record 565 as of Feb 29, 2008 Formerly Bio-Rad Laboratories to 4-75 Primary SIC — Industry Classification 2835 - Diagnostic substances Exchange: AMEX Transfer Agent: LaSalle Bank, N.A., 135 S LaSalle St. Suite 1611 Chicago, IL 60603 BioRad confocal microscope King Capital Investment Group http://kingcapital.tripod.com
PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#43 Offering 16M @ .41 for the CV PirateGary 03/05/2020 09:06:44 AM
#41 ~ Tuesday! $BIO ~ Q1 Earnings posted, pending Penny Roger$ 04/30/2012 06:45:44 AM
#40 <<< $BIO Links! >>> ~ MAC's Quick DD Penny Roger$ 04/30/2012 06:45:32 AM
#39 ~ Thursday! $BIO ~ Earnings posted, pending or Penny Roger$ 02/23/2012 05:06:42 AM
#38 Bio-Rad Reports Third-Quarter Revenue Growth of More Than SAE 11/03/2011 06:29:18 PM
#37 TPG Cap Finally Acqu Immucor [Bio-Rad mentioned, specific SAE 09/12/2011 01:47:43 PM
#36 Bio-Rad Receives FDA Premarket Application Approval for Its SAE 07/25/2011 11:15:53 AM
#35 Bio-Rad to Report Second-Quarter 2011 Financial Results Tuesday, SAE 07/12/2011 09:23:50 PM
#34 Bio-Rad Launches Antiphospholipid Syndrome IgG, IgM, and IgA SAE 06/01/2011 02:12:17 PM
#33 Bio-Rad Reports First-Quarter Currency-Neutral Revenue Growth of 4.9 SAE 05/06/2011 06:43:29 PM
#32 Bio-Rad to Report First-Quarter 2011 Financial Results Tuesday, SAE 04/13/2011 06:18:30 PM
#31 Bio-Rad Reports Record Fourth-Quarter and Full-Year 2010 Financial SAE 02/25/2011 01:10:48 AM
#30 Bio-Rad to Report Fourth-Quarter and Full-Year 2010 Financial SAE 01/28/2011 11:06:18 AM
#29 Bio-Rad Announces Public Offering of $425 Million Senior SAE 12/07/2010 12:02:29 AM
#28 Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of More SAE 11/03/2010 03:19:51 PM
#27 Bio-Rad and Axis-Shield Announce FDA Clearance and U.S. SAE 10/16/2010 03:16:59 PM
#26 Form 10-Q for BIO RAD LABORATORIES INC SAE 08/27/2010 02:45:22 PM
#25 Bio-Rad Submits Premarket Approval Application to the FDA SAE 07/27/2010 03:02:47 PM
#24 Bio-Rad Launches a Measles, Mumps, Rubella, and Varicella-Zoster SAE 06/01/2010 03:33:12 PM
#23 Bio-Rad Receives Notification From the FDA That It SAE 05/13/2010 02:02:09 PM
#22 Bio-Rad Reports First-Quarter 2010 Financial Results SAE 05/04/2010 04:37:40 PM
#21 Well being your post is number 20 I locksflooring 04/23/2010 03:22:51 PM
#20 Locksflooring, You seem to have taken my place as SAE 04/23/2010 03:03:53 PM
#19 Bio-Rad to Report First-Quarter 2010 Financial Results Tuesday, locksflooring 04/12/2010 08:38:09 AM
#18 Bio-Rad Reports Record Fourth-Quarter and Full-Year 2009 Financial locksflooring 02/24/2010 05:39:32 PM
#17 Bio-Rad Laboratories, Inc. Announces Completion of Exchange Offer locksflooring 02/05/2010 06:48:39 AM
#16 Bio-Rad to Report Fourth-Quarter and Full-Year 2009 Financial locksflooring 01/27/2010 09:34:21 PM
#15 Bio-Rad Completes the Purchase of Certain Diagnostics Businesses SAE 01/07/2010 03:24:02 PM
#14 Axis-Shield and Bio-Rad Announce Launch of New Anti-CCP SAE 01/07/2010 03:11:07 PM
#13 Bio-Rad Laboratories, Inc. Announces Commencement of Exchange Offer SAE 12/30/2009 03:23:58 AM
#12 Coverage initiated on Bio-Rad Labs by Maxim Group SAE 12/24/2009 04:14:15 AM
#11 - Current report filing (8-K) SAE 12/10/2009 03:01:26 AM
#10 Vernier and Bio-Rad to Offer Enhanced Solutions for SAE 11/25/2009 01:01:45 AM
#9 Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 11 Percent SAE 11/05/2009 02:36:22 PM
#8 Bio-Rad Signs Agreement to Acquire Certain Diagnostics Businesses SAE 10/26/2009 11:45:11 PM
#7 Bio-Rad to Report Third-Quarter 2009 Financial Results Tuesday, SAE 10/19/2009 09:43:53 AM
#6 It has certainly been awhile for Forbes (or SAE 09/23/2009 04:12:46 PM
#5 Bio-Rad Helps Raise $1.1 Million in Napa Valley SAE 09/15/2009 03:37:28 PM
#4 Bio-Rad Releases Detailed Brochure on its Bio-Plex Suspension buhg1b 04/29/2008 11:55:55 AM
#3 Chembio Signs Exclusive DPP(TM) Development Agreement With Bio-Rad buhg1b 04/17/2008 10:14:23 AM
#2 Bio-Rad Laboratories, Inc. Q4 2007 Earnings Call Transcript buhg1b 03/25/2008 01:58:03 PM
#1 Bio-Rad Reports Fourth-Quarter and Full-Year 2007 Financial Results buhg1b 03/12/2008 12:57:01 PM
Post Subject